| BCBS Federal Medical & Drug | 5.21.162 Gavreto (pralsetinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.164 Danyelza (naxitamab-gqgk) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.165 Margenza (margetuximab-cmkb) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.167 Tepmetko (tepotinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.169 Breyanzi (lisocabtagene maraleucel) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.170 Cosela (trilaciclib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.172 Fotivda (tivozanib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.173 Abecma (idecabtagene vicleucel) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.174 Jemperli (dostarlimab-gxly) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.175 Zynlonta (loncastuximab tesirine-lpyl) | 2026-03-06 |